Analystreport

Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors